Lee, Ho-Jin
Lee, Hyo Bin
Kim, Yoon Jung
Cho, Hye-Yeon
Kim, Won Ho
Seo, Jeong-Hwa
Funding for this research was provided by:
Hana Pharmaceutical (0620215310)
Article History
Received: 8 March 2023
Accepted: 21 April 2023
First Online: 2 May 2023
Declarations
:
: The Institutional Review Board of the Seoul National University Hospital approved this retrospective observational study on July 8, 2021 (Approval No. H-2105–016-1217). Written informed consent was obtained from all patients. The study followed the principles of the Declaration of Helsinki and the Strengthening the Consolidated Standards of Reporting Trials recommendations [CitationRef removed].
: Not applicable.
: The authors declare no competing interests.